In fact, MTA1 was identified by a SEREX approach, and researchers detected a natural MTA1-specific humoral immune response in prostate cancer patients but not healthy donors, indicating that MTA1 is immunogenic in patients. The gene discussed is MTA1; the disease is Familial prostate cancer.